Role of Procalcitonin, C-Reactive Protein, and WBC Count in Prediction of Colorectal Anastomotic Leak
A Prospective Cohort Study on the Role of The Triad of Procalcitonin, C-Reactive Protein, and White Blood Cell Count in The Prediction of Anastomotic Leak Following Colorectal Resections
1 other identifier
observational
205
1 country
1
Brief Summary
The interest in identifying a biological marker for the early detection of AL is growing. Such a marker could play a vital role in modern fast-track multimodal protocols, allowing safe and early discharge of patients after colorectal surgery with a low rate of readmission. C-reactive protein (CRP) has been identified as a valid parameter for detection of postoperative infectious complications after rectal resection. A serum CRP level greater than 12.4 mg/dL on postoperative day (POD) 4 is considered predictive of septic complications. According to a recent analysis, the changes in the trajectory of CRP levels might be more beneficial than a snipped point. Moreover, the trajectory has a negative predictability of up to 99.3%. Another interesting biomarker is procalcitonin (PCT), the prohormone of calcitonin, produced by parafollicular C cells in the thyroid. Normally, it has a very low plasma concentration in healthy individuals (0.01-0.05 ng/mL), and it increases during severe generalized bacterial, parasitic, or fungal infections, but not in noninfectious inflammatory reactions. Procalcitonin has been described as an early, sensitive, and specific marker of sepsis. Moreover, the plasma concentration of PCT has been used as an early predictor of infection in acute pancreatitis, secondary peritonitis, and infectious complications after thoracic, esophageal, and cardiac surgeries. In addition, elevated white blood cell (WBC) count is associated with AL after gastrointestinal surgeries. Therefore, this study was conducted to evaluate the utility of CRP, PCT, and WBC count trajectories, as separate and combined biomarkers for prediction of AL after colorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
November 18, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedJuly 26, 2024
July 1, 2024
2 years
November 18, 2021
July 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of combined CRP-PCT- WBC trajectory in prediction of anastomotic leak
Sensitivity, specificity and accuracy of combined CRP-PCT- WBCs trajectory
five days after surgery
Study Arms (1)
Patients with leak after colorectal anastomosis
Patients who developed anastomotic leak, clinical or radiologic, after colorectal resection and anastomosis
Interventions
the levels of CRP, PCT, and WBCs were assessed before surgery and after the onset of leak
Eligibility Criteria
205 patients who had colorectal surgery, all patients had a diagnosis of new or previous colorectal cancer. 56.1% of patients were males and 43.9% were females. Patient age ranged from 25 to 78 years, with a mean of 56.4 years
You may qualify if:
- adult patients of either sex who underwent colorectal surgery entailing an anastomosis
You may not qualify if:
- Patients younger than 18 years
- Patients with active infection at the time of surgery
- Patients who had received chemotherapy or radiotherapy
- Patients on long-term corticosteroid therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Suez Canal Universitylead
- Mansoura Universitycollaborator
Study Sites (1)
Mansoura university hospital
Al Mansurah, Dakahlia Governorate, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of surgery
Study Record Dates
First Submitted
November 18, 2021
First Posted
December 15, 2021
Study Start
March 1, 2018
Primary Completion
March 1, 2020
Study Completion
April 30, 2020
Last Updated
July 26, 2024
Record last verified: 2024-07